Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Pennington Biomedical Researchers Examine Low Testosterone Screening Rates Among U.S. Army Personnel
Study published in JAMA estimates that about 1 in 4 active-duty male soldiers has a single morning testosterone measurement below a commonly used clinical threshold - October 17, 2026 - Pennington Biomedical Research Center
NuuVive Peptides Study Finds 1 in 7 Online Peptide Lab Reports Gives Buyers No Way to Check It With the Lab
A NuuVive Peptides study of 13,923 lab reports posted by 129 online peptide stores finds that a third have no link to the lab's own record, about 1 in 7 gives buyers no way to check it with the lab at all, and the typical report is five months old. - October 16, 2026 - NuuVive Peptides
Pennington Biomedical's “Be the Reason Kids Greaux Healthy” Connects Experts to Advance Childhood Obesity Care
Annual conference connects research, healthcare and community strategies to address childhood obesity - October 16, 2026 - Pennington Biomedical Research Center
Pennington Biomedical Study Links Life-Course Clinical Obesity to Signs of Brain Health Changes in Midlife
Bogalusa Heart Study findings provide new evidence connecting cumulative clinical obesity with white matter changes in the brain - October 16, 2026 - Pennington Biomedical Research Center
Study from Pennington Biomedical Reveals How Warm Temperatures Influence Appetite and Weight Gain
Scientists identified neurons that connect warm temperatures with appetite and energy expenditure, providing new insight into how environment influences body weight. - October 09, 2026 - Pennington Biomedical Research Center
CJC-1295 + Ipamorelin with DAC vs. No DAC: Kylo Peptides Clarifies Labeling Across Its Research Catalog
Kylo Peptides clarifies CJC-1295 + Ipamorelin labeling so researchers can tell CJC-1295 with DAC from the no-DAC form, Mod GRF 1-29, in its catalog. - October 07, 2026 - Kylo Research Labs LLC
THROMBOLEX Announces Interim RAPID-PE Results
THROMBOLEX Announces Interim RAPID-PE Results Showing Favorable Safety and Reproducible Multicenter Results in Acute Pulmonary Embolism. Mechanically channeled thrombolysis procedure disrupts and dissolves thrombus in a single on-the-table session. - October 05, 2026 - Thrombolex, Inc.
Pennington Biomedical and Others Examine What Science Says About Ultraprocessed Foods and the Aging Brain
Dr. Owen Carmichael and an international team examine evidence linking diet, brain health and cognitive aging in the 2026 Annual Review of Nutrition. - October 04, 2026 - Pennington Biomedical Research Center
Pennington Biomedical and Collaborators Identify Brain Circuit Linked to Food Cravings During Pregnancy
Study in Nature Neuroscience provides new insight into how pregnancy alters brain circuits that influence food motivation. - October 04, 2026 - Pennington Biomedical Research Center
Pennington Biomedical Researchers Help Advance New Tool for Analyzing Continuous Glucose Monitoring Data
GVC-Calc provides researchers with a scalable and transparent approach to analyzing data from continuous glucose monitors. - October 04, 2026 - Pennington Biomedical Research Center
Pennington Biomedical Researchers Offer New Perspective on How Protein Restriction May Promote Healthy Aging and Longevity
Published in Cell Metabolism, the paper suggests protein restriction triggers a coordinated whole-body response that may help explain its effects on healthy aging. - October 04, 2026 - Pennington Biomedical Research Center
New York Health Welcomes Nephrologist, Dr. Oscar Andres Rodriguez Ayala
New York Health (NY Health) is proud to announce the addition of nephrologist, Dr. Oscar Andres Rodriguez Ayala. Beginning October 1, 2026, Dr. Rodriguez Ayala will practice at NY Health’s office at 5316 Nesconset Highway, Port Jefferson Station, NY 11776. “We are pleased to welcome Dr. - October 02, 2026 - New York Health
Microvascular Therapeutics to Present Phase II CardiSon™ Data at 40th International Bubble Conference in Chicago
Next-generation ultrasound enhancing agent demonstrated improved left ventricular opacification and significantly reduced acoustic shadowing - October 02, 2026 - Microvascular Therapeutics, Inc.
Canada Peptide Research Co. Expands Batch-Level Documentation and Research Education Resources
Canada Peptide Research is a Vancouver-based supplier serving the Canadian research market. The company focuses on research materials, batch-level documentation, third-party analytical testing where available, educational resources and Canadian fulfillment. - October 01, 2026 - Canada Peptide Research
ALS TDI to Convene ALS Research, Industry, and Community Leaders at 2026 Summit and White Coat Affair Gala
This October, two Boston events will bring people together to share research updates, build connections, and accelerate progress for people with ALS. - September 23, 2026 - ALS Therapy Development Institute
SignaBlok Awarded NIH NIDDK Grant to Develop Novel TREM-1 Antagonist Drug for Inflammatory Bowel Disease
SignaBlok, Inc. has been awarded a Phase I SBIR grant from the NIH NIDDK to advance the development of a novel mechanism-based therapy for inflammatory bowel disease (IBD). The award supports SignaBlok's differentiated approach to targeting TREM-1 in IBD. - September 18, 2026 - SignaBlok, Inc.
Pennington Biomedical Researcher Dr. Emily Flanagan Launching Study on Infant Energy Balance and Early-Life Growth
First-of-its-kind study examining how energy intake and expenditure influence infant growth and future obesity risk. - September 05, 2026 - Pennington Biomedical Research Center
Pennington Biomedical Researchers Find Peroxisomes Help Protect Insulin and Maintain Beta Cell Health
Study reveals impaired peroxisomal function can increase insulin secretion while promoting insulin oxidation and disrupting pancreatic beta cell maturity. - September 03, 2026 - Pennington Biomedical Research Center
Beyond the Scale: Emerge Weight Loss Expands GLP-1 Telehealth Care to Support Women Living With PCOS and Endometriosis
As emerging research illuminates tirzepatide's metabolic and anti-inflammatory effects, Emerge extends compassionate, medically supervised weight loss care from board-certified providers to women whose health needs reach far beyond a number on the scale. - September 02, 2026 - Emerge Weight Loss, LLC
Helix BioMedix Completes $2 Million Private Placement to Advance Xeroderma Pigmentosum Development Program
Financing strengthens balance sheet and accelerates advancement of proprietary DNA repair technology targeting UV-induced DNA damage. - August 29, 2026 - Helix BioMedix, Inc
Pennington Biomedical’s 2026 Childhood Obesity Conference: “Be the Reason Kids Greaux Healthy” to be Held Sept. 24
Event brings together healthcare professionals, researchers, educators and community leaders to explore strategies for preventing and treating childhood obesity. - August 27, 2026 - Pennington Biomedical Research Center
Pennington Biomedical's Dr. Steven Heymsfield Co-Authors Editorial Highlighting the Unanticipated Benefits of GLP-1 Medications
Dr. Steven Heymsfield and Dr. Adam Gilden’s Obesity journal editorial highlights emerging benefits and questions surrounding this rapidly expanding class of medications - August 26, 2026 - Pennington Biomedical Research Center
Four Peer-Reviewed Clinical Study Publications Build a Substantial Evidence Base for Oxaloacetate CFS in ME/CFS and Long COVID
Research published in the Journal of Translational Medicine, Frontiers in Neurology and Frontiers in Neuroscience journals finds oxaloacetate improves ME/CFS and Long COVID symptoms including physical fatigue, mental fatigue, cognition, symptom burden and upright activity. - August 18, 2026 - Terra Biological LLC
New 2026 Report Reveals an AI/LLM Gap Between Biopharma Sponsors and Their CROs/Vendors
Life Science Strategy Group looks beyond frontier-AI hype to show how biopharma teams use AI and LLMs in daily work, and where their CRO and vendor partners are falling short. 71% of sponsors rate their own AI/LLM output highly. Only 27% say the same of their CROs and vendors. - August 12, 2026 - Life Science Strategy Group, LLC
ecotera health Submits Decentralized Urine Microplastics / Nanoplastics Observational Study for IRB Review
Study will evaluate an at-home approach to longitudinal microplastics / nanoplastics monitoring in urine using the EcoExposure™ platform - August 08, 2026 - ecotera health
New Approach to Obesity Classification Could Better Guide Treatment Decisions
Pennington Biomedical researchers examine limitations of “metabolically healthy obesity” and support a framework that connects treatment to organ dysfunction. - August 02, 2026 - Pennington Biomedical Research Center
Pennington Biomedical Researchers Part of National Study Showing Proven Childhood Obesity Treatment Also Works at Pediatrician’s Office
Family-based treatment helped nearly half of kids in clinical trial reach healthier weight - July 31, 2026 - Pennington Biomedical Research Center
Microvascular Therapeutics Highlights the Future of Ultrasound Theranostics in Comprehensive Wiley Review
Microvascular Therapeutics, Inc. (MVT) today announced publication of a comprehensive review in Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (WIREs Nanomedicine and Nanobiotechnology), a leading peer-reviewed journal with a 2025 Journal Impact Factor of 8.6, entitled,... - July 28, 2026 - Microvascular Therapeutics, Inc.
Pennington Biomedical Researchers to Present at NUTRITION 2026
Researchers will contribute to sessions focused on organoid models, GLP-1 therapies, protein intake, early-life nutrition, vitamins and minerals, artificial intelligence and more. - July 27, 2026 - Pennington Biomedical Research Center
Biomarker Discovery by Pennington Biomedical and Colleagues Could Advance Treatments for Obesity-Related Health Risks
Study published in Metabolism identifies endotrophin as dynamic marker of changes in body fat and metabolic health - July 25, 2026 - Pennington Biomedical Research Center
Pennington Biomedical, Our Lady of the Lake and Metamor Institute Show Promising Outcomes for Bariatric Surgery in Adolescents and Young Adults with Severe Obesity
Research collaboration highlights safe surgical outcomes and significant health improvements in young patients in Louisiana - July 15, 2026 - Pennington Biomedical Research Center
Clinical Based Evidence of Eminent Spine's 3D Printed Titanium Pedicle Screw
Eminent Spine, a leader in advanced 3D implant technology, releases the early clinical and implant results of the world's first FDA 510(k) approved 3D printed titanium pedicle screw. The proprietary 3D printed pedicle screw, designed and manufactured by Eminent Spine received FDA 501(k) clearance... - July 14, 2026 - Eminent Spine
Pennington Biomedical's Dr. Tim Allerton Studying a New Approach to Advance Heart Failure Research
Dr. Allerton to research one of the fastest-growing forms of heart failure - July 13, 2026 - Pennington Biomedical Research Center
Pennington Biomedical Releases RURAL Health Study's Key Drivers of Chronic Disease in Franklin Parish, Louisiana
Franklin Parish data now available to go along with Assumption Parish data revealed earlier this year from Pennington Biomedical. - July 07, 2026 - Pennington Biomedical Research Center
Hemanext Expands Commercial Footprint Through Strategic Partnership with OneBlood
Hemanext Inc. announced a strategic production partnership with OneBlood, one of the nation's largest independent blood centers, marking a significant milestone in Hemanext's commercial expansion and accelerating adoption of Hemanext ONE® across the United States. - July 06, 2026 - Hemanext
New York Cancer & Blood Specialists Welcomes Medical Oncologist-Hematologist, Dr. Neel Patel
New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, proudly announces the addition of Dr. Neel Patel, a hematologist-oncologist dedicated to providing evidence-based, compassionate cancer care. Beginning July 1, 2026, Dr. Patel will be practicing... - July 04, 2026 - New York Cancer & Blood Specialists
Microvascular Therapeutics to Present Late-Breaking Clinical Data on CardiSon™ (MVT-100) at the 2026 American Society of Echocardiography Meeting.
Clinical Study Demonstrates Superior Left Ventricular Opacification and Significantly Reduced Acoustic Shadowing Compared with Definity®. - June 26, 2026 - Microvascular Therapeutics, Inc.
The Methodist University Cape Fear Valley Health School of Medicine, N.C.’s Newest Med School, Holds Ribbon-Cutting Ceremony
Forever changing the future of healthcare in Southeastern North Carolina, the new School of Medicine (SOM) was announced in 2023 through a partnership between MU and Cape Fear Valley Health and the ribbon cutting helped signify once again how the dream has truly become the reality. - June 24, 2026 - Methodist University
Hundreds of Cyclists to Ride Across Three States to Advance ALS Research
More than 400 cyclists, volunteers, and supporters will gather in Durham, New Hampshire on June 27–28 for the 24th annual Tri-State Trek, a two-day cycling event benefiting the ALS Therapy Development Institute (ALS TDI), the world's most comprehensive drug discovery institute dedicated... - June 23, 2026 - ALS Therapy Development Institute
Pennington Biomedical Recruiting Participants for Study on Weight Loss Using GLP-1-Based Therapy
Led by LSU Boyd Professor Dr. Eric Ravussin, the Novo Expenditure trial examines a hormone-based investigational treatment and its effects on energy use and weight loss - June 18, 2026 - Pennington Biomedical Research Center
Pennington Biomedical Seeks Volunteers for Study on How the Body Regulates Weight
Study to explore how energy intake, energy expenditure and biological responses interact to influence body weight - June 18, 2026 - Pennington Biomedical Research Center
Dr. Owen Carmichael Awarded James W. and Neil Ann Parks Professorship for Dementia Research, Prevention and Treatment at Pennington Biomedical
Dr. Carmichael's research focuses on developing and applying advanced biomedical imaging techniques to better understand Alzheimer’s disease, dementia, brain aging and the effects of lifestyle and metabolic health on cognitive decline - June 18, 2026 - Pennington Biomedical Research Center
Pennington Biomedical Recruiting Adults with Type 2 Diabetes for Avocado Nutrition Study
Researchers to examine whether daily avocado consumption can improve blood sugar control and insulin sensitivity. - June 18, 2026 - Pennington Biomedical Research Center
MyConcussionDR Announces Public Support for the American Center for Cures
Brain health education team joins national initiative to fund the prevention and cure of major diseases, citing its shared commitment to families, accountability, and long-term neurological health. - June 08, 2026 - MyconcussionDR
NuRev Wholesale Launches Dedicated Platform for Wholesale Research Peptide Procurement
New Wholesale Program Designed to Support Laboratories, Research Organizations, Distributors, and Qualified Business Buyers - June 07, 2026 - NuRev Wholesale
Alera Bio Appoints David McCullough as Chief Executive Officer
Alera Bio announced the appointment of David McCullough as Chief Executive Officer. An experienced biotechnology executive, McCullough will lead corporate strategy, financing, organizational development, and execution of the company’s clinical and regulatory roadmap. He will oversee advancement of AB-101, Alera’s novel therapy for MCT-8 deficiency, as the company works to bring new hope to patients and families affected by this devastating rare neurodevelopmental disorder. - June 04, 2026 - Alera Bio
New York Cancer & Blood Specialists Welcomes Medical Oncologist-Hematologist, Dr. Shuwen Lin
New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, proudly announces the addition of Dr. Shuwen Lin, a board-certified hematologist-oncologist dedicated to providing evidence-based, compassionate cancer care. Beginning June 1, 2026, Dr. Lin will... - June 03, 2026 - New York Cancer & Blood Specialists
LSU's Pennington Biomedical Research Center Names 2025 Publication of the Year
Dr. Carmichael’s award-winning publication represents a landmark contribution to obesity research and translational medicine. - May 30, 2026 - Pennington Biomedical Research Center
Pennington Biomedical: New International Study Highlights Impact of Restrained Sitting on Movement Behaviors in Young Children
Researchers explored how time spent restrained in devices such as car seats and strollers may influence children's ability to meet movement behavior recommendations - May 30, 2026 - Pennington Biomedical Research Center
SPARK Industries Announces New MRI Signal Analysis Platform for Neurological Disease and Cancer Research
SPARK Industries announced advancements in its patent-pending MRI signal-analysis platform designed to detect previously unresolved neurological and structural signatures within raw MRI data. Internal validation across 1,000+ clinical MRI cases involving TBI, Alzheimer’s, Parkinson’s, and prostate cancer demonstrated consistent signal relationships associated with known disease states. SPARK is now pursuing blinded third-party validation trials. - May 27, 2026 - SPARK Industries Corporation